References Tesamorelin LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institutes of Health, NIDDK (2018) Tesamorelin (Subcutaneous route) Drug Information Mayo Clinic / IBM Merative (2025) Effects of tesamorelin (TH9507), a growth hormonereleasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials J
All AbMole products are for research use only, cannot be used for human consumption
It supports tissue repair, inflammation modulation, and regenerative signaling across muscles, tendons, ligaments, and the gut lining, making it a focus for research in angiogenesis research, injury tissue remodelling, and wellness
A collaboration between Oragenics, Inspirevax, and the National Research Council of Canada has led to the development of NT-CoV-2 (Table 2)
It binds to adipose tissue and triggers breakdown of stored fat while blocking new fat storage (reesterification) in adipocytes [4]
Shaking can shear and destroy the peptide chains